ESR1 and breast carcinoma: Ryohei [160] combined spatial transcriptomics(ST) and single-cell RNA sequencing(scRNA-seq) techniques to analyze xenografts (PDXs) originating from patients with estrogen receptor-positive (ER+) breast cancer in order to reveal intratumor heterogeneity and estrogen-dependent tumor growth of the Significance.